Home
Scholarly Works
Oral direct Factor Xa inhibitors versus...
Journal article

Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis

Contact the Experts team